No Data
No Data
BTIG Maintains Tactile Systems Technology(TCMD.US) With Buy Rating, Maintains Target Price $16
BTIG analyst Ryan Zimmerman maintains $Tactile Systems Technology(TCMD.US)$ with a buy rating, and maintains the target price at $16.According to TipRanks data, the analyst has a success rate of 48.7%
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA), BioMarin Pharmaceutical (BMRN) and Tactile Systems Technology (TCMD)
Results: Tactile Systems Technology, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Does Tactile Systems Technology (TCMD) Have the Potential to Rally 57.31% as Wall Street Analysts Expect?
Tactile Systems Technology Second Quarter 2024 Earnings: EPS Beats Expectations
Oppenheimer Maintains Tactile Systems Technology(TCMD.US) With Buy Rating, Maintains Target Price $20
Oppenheimer analyst Suraj Kalia maintains $Tactile Systems Technology(TCMD.US)$ with a buy rating, and maintains the target price at $20.According to TipRanks data, the analyst has a success rate of 5